Planning

Antenatal Testing Maternity Screening DNA Reflex pathway

  • Kingston and Richmond Hospital NHS Foundation Trust

F01: Prior information notice (prior information only)

Notice identifier: 2026/S 000-015710

Procurement identifier (OCID): ocds-h6vhtk-065957

Published 20 February 2026, 2:01pm



Section one: Contracting authority

one.1) Name and addresses

Kingston and Richmond Hospital NHS Foundation Trust

Procurement Department, Vera Brown House

Kinston Upon Thames

KT2 7QB

Contact

Charley Choules

Email

charlotte.choules@stgeorges.nhs.uk

Country

United Kingdom

Region code

UKI63 - Merton, Kingston upon Thames and Sutton

Internet address(es)

Main address

https://www.kingstonhospital.nhs.uk/

Buyer's address

https://www.kingstonhospital.nhs.uk/

one.3) Communication

Additional information can be obtained from the above-mentioned address

Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at

https://atamis-1928.my.site.com/s/Welcome

one.4) Type of the contracting authority

Body governed by public law

one.5) Main activity

Health


Section two: Object

two.1) Scope of the procurement

two.1.1) Title

Antenatal Testing Maternity Screening DNA Reflex pathway

two.1.2) Main CPV code

  • 85100000 - Health services

two.1.3) Type of contract

Services

two.1.4) Short description

DNA Reflex pathway at Kingston and Richmond Foundation Trust (KRFT)

two.1.6) Information about lots

This contract is divided into lots: No

two.2) Description

two.2.3) Place of performance

NUTS codes
  • UKI63 - Merton, Kingston upon Thames and Sutton

two.2.4) Description of the procurement

At Kingston and Richmond Foundation Trust (KRFT), an alternative service is provided to the one that is recommended by the National Screening Committee and it is outside of the National pathway. Continuation with the DNA Reflex pathway was based upon our findings that our pathway is fair and equitable for all patients, it reduces anxiety caused by recalling patients back to discuss screen positive results from their first line of screening.

The foetal abnormality screening pathway for NHS patients is designed to detect any potential abnormalities or conditions in the developing baby during pregnancy. The screening process aims to provide early identification of conditions, allowing for informed decisions and, where possible, early interventions. The pathway includes specific tests at key stages of pregnancy.

Conditions the service screen for: Down’s Syndrome (Trisomy 21), Edwards' Syndrome (Trisomy 18), Patau’s Syndrome (Trisomy 13).

Service offers comprehensive NIPT screening for higher chance results. KRFT use the ‘cut-off’ >1:300. Any result greater than 1 in 300 is automatically processed if the patient has agreed to screening.

NIPT is a refined and accurate test at a detection rate of up to 99%. The screening team discuss results greater than 1 in 10 prior to sending the NIPT sample. Results are communicated in <2 weeks.

The laboratory meets all the commissioning standards set by the FASP programme. They have all their internal specifications and are regularly ‘inspected’ to ensure they meet the standards/recommendations by the commissioners and the FASP programme.

two.2.14) Additional information

This is a Provider Selection Regime (PSR) intended approach notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award.

The intention is to award a contract using the Most Suitable Provider Process.

two.3) Estimated date of publication of contract notice

1 April 2026


Section four. Procedure

four.1) Description

four.1.8) Information about the Government Procurement Agreement (GPA)

The procurement is covered by the Government Procurement Agreement: No